Deoxycholic Acid

脱氧胆酸

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameDeoxycholic Acid
Drug Alias Name去氧胆酸acidum deoxycholicumBellacholineBelkyraKybella +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionG-protein coupled receptor agonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsLocalized submental fatObesityNeurofibromatosis 1 +[5] 
Global Approved IndicationsLocalized submental fat
Approved Indications in ChinaLocalized submental fat
Original Approved Country/TerritoryUnited States
Original Approved Date2015/04/29
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKythera
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins UniversityLg Chemical LtdAbbvie Inc +[4] 
Inactive CompaniesKythera Biopharmaceuticals IncUniversity Of California San DiegoBeijing Cangwei Xinkang Pharmaceutical R & D Co Ltd +[6] 
Active IndicationsLocalized submental fatNeurofibromatosis 1Neurofibroma +[4] 
Inactive IndicationsObesity

Other Information

ATC CodeD11AX24
Related LinksWikipediaDrugBankKEGG